27 Jun, 2023 Part 2: APOE Genotyping in Clinical Practice: Pros and Cons alzheon2023-07-20T10:30:08-04:00June 27th, 2023| Read More
27 Jun, 2023 Part 1: The Role of APOE Genotyping in Alzheimer’s Disease Risk Stratification alzheon2023-07-20T10:29:35-04:00June 27th, 2023| Read More
27 Jun, 2023 Unprecedented Reduction in Key Alzheimer’s Biomarker for Patients Treated With ALZ-801 alzheon2023-07-28T10:07:13-04:00June 27th, 2023| Read More
27 Jun, 2023 A First of Its Kind, ALZ-801 Aims To Preserve Memories, Save Lives: An Exclusive Interview with Dr. Martin Tolar alzheon2023-07-27T17:26:57-04:00June 27th, 2023| Read More
27 Jun, 2023 The Science Behind the Drug That May Stop Alzheimer’s Disease in Its Tracks alzheon2023-07-17T13:26:16-04:00June 27th, 2023| Read More